MedTrace Logo

Intervention Program Among University Student to Promote Physical Activity and Reduce the Sedentary Time

NCT05019482 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-06-29

No results posted yet for this study

Summary

Since the beginning of the COVID-19 pandemic, university students have faced many challenges and without any preparation. Studies conducted during the first lockdown show an increase in unhealthy lifestyles.

This study will be proposed to students from University of Nimes an 8-week physical activity program. Two groups will be constituted: the first will benefit from of innovative physical activity program on the base of the co-construction with users (Experimental Group), another that will not benefit from any intervention (Control Group). Investigators plan to include approximately 90 university students, 45 in each group.

The main goal of the study is to propose innovative program to promote PA (Physical Activity) and reduce ST (Sedentary Time) of young adults aged over 18 from university of Nîmes. The levels of PA and ST of the experimental group will be compared to a control group with the realization of pre and post intervention measures.

Conditions

  • Physical Activity
  • Sedentary Behavior
  • Young Adults
  • Student

Interventions

BEHAVIORAL

University-based intervention to promote PA and reduce ST

This intervention was realized with all college student and involved: 1. Design-based innovative workshops during the first week; 2. 8-weeks program of Physical Activity constructed by users 3. Information session focusing on the promotion of active behaviors 4. Feedback provided to the users with an individualized report

Sponsors & Collaborators

  • University of Nimes

    lead OTHER

Principal Investigators

  • ELODIE CHARBONNIER, PhD · UNIVERSITE DE NIMES - UPR APSY-v

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-06
Primary Completion
2021-12-17
Completion
2021-12-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05019482 on ClinicalTrials.gov